News

Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study
Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR ...
Finanznachrichten8d
Acousia Therapeutics GmbH: Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study
TÜBINGEN, Germany, April 29, 2025 /PRNewswire/ -- Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, ...
Yahoo Finance8d
Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study
TÜBINGEN, Germany, April 29, 2025 /PRNewswire/ -- Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study ...
Mena FN8d
Acousia Therapeutics Reaches 50% Patient Enrollment Milestone In Phase 2 PROHEAR Study
Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study , evaluating ACOU085 (INN: bimokalner) for the ...
The Globe and Mail13d
Hearing Loss Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight
Explore DelveInsight’s expert-driven report today! @ Hearing Loss Unmet Needs Acousia Therapeutics, Decibel Therapeutics, Otonomy Inc., Sensorion, Autifony Therapeutics, Auris Medical ...